Metabolism and action of urodilatin infusion in healthy volunteers

Clinical Pharmacology and Therapeutics

Volumn 64, Issue 1, 1998, Pages 73-86

  Carstens, Jan ^a   Jensen, Kaare T ^a   Pedersen, Erling B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EDETATE CHROMIUM CR 51; IODOHIPPURATE SODIUM I 125; LITHIUM; PLACEBO; URODILATIN;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG URINE LEVEL; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; MEAN ARTERIAL PRESSURE; NAUSEA; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PULSE RATE; RADIOIMMUNOASSAY; SODIUM EXCRETION; SODIUM URINE LEVEL; SWEATING; URINE FLOW RATE; VERTIGO;

ADULT; ALDOSTERONE; ANGIOTENSIN II; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BODY WEIGHT; CROSS-OVER STUDIES; CYCLIC GMP; DIURETICS; DOUBLE-BLIND METHOD; HEART RATE; HEMATOCRIT; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; LITHIUM; MALE; METABOLIC CLEARANCE RATE; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; RENIN; SODIUM;

EID: 0031820556     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90025-X     Document Type: Article

References (41)

1. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG. Isolation and structural analysis of "urodilatin," a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 1988;66:752-9.
2. Feller SM, Gagelmann M, Forssmann WG. Urodilatin: a newly described member of the ANP family. Trends Pharmacol Sci 1989;10:93-4.
3. Greenwald JE, Needleman P, Wilkins MR, Schreiner GF. Renal synthesis of atriopeptin-like protein in physiology and pathophysiology. Am J Physiol 1991;260:F602-7.
4. Greenwald JE, Ritter D, Tetens E, Rotwein PS. Renal expression of the gene for atrial natriuretic factor. Am J Physiol 1992;263:F974-8.
5. Maack T, Okolicany J, Koh GY. Price DA. Functional properties of atrial natriuretic factor receptors. Semin Nephrol 1993; 1:50-60.
6. Gunning ME, Otuechere G, Zeidel ML. Mechanism of urodilatin (ANP 95-126; URO) inhibition of Na+ transport in rabbit inner medullary collecting duct (IMCD) cells [abstract]. J Am Soc Nephrol 1991;2:402(A).
7. Saxenhofer H, Fitzgibbon WR, Paul RV. Urodilatin: binding properties and stimulation of cGMP generation in rat kidney cells. Am J Physiol 1993;264:F267-73.
8. Light DB, Corbin J, Stanton BA. Dual ion-channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase. Nature 1990;344:336-9.
9. Drummer C, Fiedler F, König A, Gerzer R. Urodilatin a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man. J Am Soc Nephrol 1991;1:1109-13.
10. Heer M, Drummer C, Baisch F, Gerzer R. Long-term elevations of dietary sodium procedure parallel increase in the renal excretion of urodilatin and sodium. Pflugers Arch 1993;425:390-4.
11. Olins GM, Spear KL, Siegel NR, Reinhard EJ, ZurcherNeely HA. Atrial peptide inactivation by rabbit-kidney brush-border membranes. Eur J Biochem 1987;170:431-4.
12. Shima M, Seino Y, Torikai S, Imai M. Intrarenal localization of degradation of atrial natriuretic peptide: in iso-lated glomeruli and ortical nephron segments. Life Sci 1988;43:357-63.
13. Gagelmann M, Hock D, Forssmann WG. Urodilatin (CDD/ANF 95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (a-hANP/CDD 99-126). FEBS Lett 1988;233:249-54.
14. Saxenhofer H, Rashelli A, Weidmann P, Forssmann WG, Bub A, Ferrari P, et al. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am J Physiol 1990;259:F832-8.
15. Riegger GAJ, Elsner D, Forssmann WG, Kromer EP. Effects of ANP-(95-126) in dogs before and after induction of heart failure. Am J Physiol 1990;259:H1643-8.
16. Bestie MH, Bie P. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs. Acta Physiol Scand 1993; 149:77-83.
17. Kentsch M, Ludwig D, Drummer C, Gerzer R, Miiller-Esch G. Haemodynamic and renal effects of urodilatin in healthy volunteers. Eur J Clin Invest 1992;22:319-25.
18. Abassi ZA, Tate J, Hunsberger S, Klein H, Trachewsky D, Keiser HR. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Am J Physiol 1992;263:E870-6.
19. Carstens J, Jensen KT, Pedersen EB. Effect of urodilatin infusion on renal hemodynamics, tubular function and vasoactive hormones. Clin Sci 1997;92:397-407.
20. Tan ACITL, Russel FGM, Thien T, Benraad TJ. Atrial natriuretic peptide: an overview of clinical pharmacology and pharmacokinetics. Clin Pharmacokinet 1993;24:28-45.
21. Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971;28:91-100.
22. Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 1984;37:217-23.
23. Kappelgaard AM, Nielsen MD, Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976;67:299-306.
24. Rask-Madsen J, Bruunsgaard A, Munck O, Nielsen MD, Worming H. The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass oper-ation. Scand J Gastroenterol 1974;9:417-26.
25. Pedersen EB, Danielsen H, Spencer ES. Effect of indapamid on renal plasma flow, glomerular filtration rate and arginine-vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984;26:543-7.
26. Jensen KT, Carstens J, Ivarsen P, Pedersen EB. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma: reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997;57:529-40.
27. Carstens J, Jensen KT, Ivarsen P, Rasmussen LM, Pedersen EB. Development of a urodilatin-specific antibody and radioimmunoassay for urodilatin in human urine. Clin Chem 1997;43:638-43.
28. Brier ME, Brier RA, Luft FC, Aronoff GR. Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in isolated perfused rat kidney. J Pharmacol Exp Ther 1987;243:868-73.
29. Villarreal D, Freeman R, Johnson RA. Renal effects of ANF (95-126), a new atrial peptide analogue, in dogs with experimental heart failure. Am J Hypertens 1991;4:508-15.
30. Abassi ZA, Powell J, Golamb E, Keiser HR. Renal and systemic effects of urodilatin in experimental highoutput heart failure. Am J Physiol 1992;262:F615-21.
31. Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 1986;324:473-6.
32. Hildebrandt DA, Leland Mizelle H, Brands MW, Hall JE. Comparison of renal actions of urodilatin and atrial natriuretic peptide. Am J Physiol 1992;262:R395-9.
33. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990;3:665-99.
34. Bruun NE. On the role of atrial natriuretic factor in nor-motensive and hypertensive man, with special emphasis on lithium clearance in the assessment of renal tubular sodium handling. Dan Med Bull 1993;40:582-600.
35. Koomans HA, Boer WH, Mees EJD. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989;36:2-12.
36. Skøtt P. Lithium clearance in the evaluation of segmental renal tubular reabsorption of sodium and water in diabetes mellitus. Dan Med Bull 1994;41:23-37.
37. Schulz-Knappe P, Honrath U, Forssmann WG, Sonnenberg H. Endogenous natriuretic peptides: effect on collecting duct function in rat kidney. Am J Physiol 1990;259:F415-8.
38. Gunning ME, Ballermann BJ, Silva P, Brenner BM, Zeidel ML. Characterization of ANP receptors in rabbit inner medullary collecting duct cells. Am J Physiol 1988;255: F324-30.
39. Ballermann BJ, Zeidel ML. Atrial natriuretic hormone. In: Seldin DW, Giebisch G, editors. The kidney: physiology and pathophysiology. New York: Raven; 1992. p. 1843-84.
40. Meyer M, Richter R, Brunkhorst R, Wrenger E, Schulz-Knappe P, Kist A, et al. Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects. Am J Physiol 1996;271:F489-97.
41. Kentsch M, Ludwig D, Drummer C, Gerzer R, Miiller-Esch G. Severe hypotension and bradycardia after con-tinuous intravenous infusion of urodilatin (ANP 95-126) in a patient with congestive heart failure. Eur J Clin Invest 1995;25:281-3.